Investigational drugs inhibiting complement for the treatment of geographic atrophy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Investigational drugs inhibiting complement for the treatment of geographic atrophy
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume -, Issue -, Pages 1-8
Publisher
Informa UK Limited
Online
2023-10-30
DOI
10.1080/13543784.2023.2276759
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial
- (2023) Sunil S. Patel et al. EYE
- Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
- (2023) Arshad M Khanani et al. LANCET
- COMPLEMENT INHIBITION FOR GEOGRAPHIC ATROPHY
- (2023) Richard F. Spaide et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The Complement System, Aging, and Aging-Related Diseases
- (2022) Runzi Zheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Soluble MAC is primarily released from MAC-resistant bacteria that potently convert complement component C5
- (2022) Dennis J Doorduijn et al. eLife
- Future perspectives for treating patients with geographic atrophy
- (2022) Anat Loewenstein et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- C1q and the classical complement cascade in geographic atrophy secondary to age-related macular degeneration
- (2022) Ted Yednock et al. International Journal of Retina and Vitreous
- Characterizing New-Onset Exudation in the Randomized Phase 2 FILLY Trial of Complement Inhibitor Pegcetacoplan for Geographic Atrophy
- (2021) Charles C. Wykoff et al. OPHTHALMOLOGY
- Geographic atrophy: where we are now and where we are going
- (2021) Alyse J. Richard et al. CURRENT OPINION IN OPHTHALMOLOGY
- Inhibition of Complement C3 in Geographic Atrophy with NGM621: Phase 1 Dose-Escalation Study Results
- (2021) Charles C. Wykoff et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pegcetacoplan: First Approval
- (2021) Sheridan M. Hoy DRUGS
- C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2020) Glenn J. Jaffe et al. OPHTHALMOLOGY
- Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration.
- (2019) David S. Liao et al. OPHTHALMOLOGY
- The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease
- (2019) Federica Defendi et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- The Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration
- (2018) Monika Fleckenstein et al. OPHTHALMOLOGY
- Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration
- (2018) Frank G. Holz et al. JAMA Ophthalmology
- Age-related macular degeneration
- (2018) Paul Mitchell et al. LANCET
- Proliferative vitreoretinopathy: A new concept of disease pathogenesis and practical consequences
- (2016) J. Carlos Pastor et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Retinal Pigment Epithelial Cells Mitigate the Effects of Complement Attack by Endocytosis of C5b-9
- (2015) Apostolos Georgiannakis et al. JOURNAL OF IMMUNOLOGY
- Clinical and Genetic Factors Associated with Progression of Geographic Atrophy Lesions in Age-Related Macular Degeneration
- (2015) Felix Grassmann et al. PLoS One
- Growth of Geographic Atrophy on Fundus Autofluorescence and Polymorphisms ofCFH,CFB,C3,FHR1-3, andARMS2in Age-Related Macular Degeneration
- (2014) Josemaria Caire et al. JAMA Ophthalmology
- Toward a structure-based comprehension of the lectin pathway of complement
- (2013) Troels R. Kjaer et al. MOLECULAR IMMUNOLOGY
- Complement factor H genetic variant and age-related macular degeneration: effect size, modifiers and relationship to disease subtype
- (2012) Reecha Sofat et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Therapeutic potential of complement modulation
- (2009) Eric Wagner et al. NATURE REVIEWS DRUG DISCOVERY
- CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD
- (2009) Hendrik P. N. Scholl et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now